Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
pharma companies
September 2022
August 2022
DOLO freebies: SC asks Centre’s reply on price control mechanism
NGO FMRAI tells SC that DOLO drug maker distributed freebies worth ₹1,000 crore to doctors for prescribing its 650 mg dosages
